BackNgm Biopharmaceuticals Overview

Ngm Biopharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for NGM.

Quarterly SG&A Expenses

$7.94M
↓ 18.63% YoY

As of Dec 31, 2023

Annual SG&A Expenses (TTM)

$37.84M
↓ 6.6% YoY

Trailing 12 months ending Dec 31, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin